Ustekinumab dosing, persistence, and discontinuation patterns in patients with moderate-to-severe psoriasis

Journal of Dermatological Treatment

Volumn 26, Issue 2, 2015, Pages 113-120

  Cao, Zhun ^a   Carter, Chureen ^b   Wilson, Kathleen L ^a   Schenkel, Brad ^b  

^a IBM WATSON HEALTH   (United States)

^b Janssen Scientific Affairs LLC   (United States)

Author keywords

Discontinuation; Dosing; Persistence; Ustekinumab

Indexed keywords

ADALIMUMAB; ETANERCEPT; USTEKINUMAB;

ADULT; AGED; ARTICLE; BIOLOGICAL THERAPY; CARDIOVASCULAR DISEASE; CHARLSON COMORBIDITY INDEX; DRUG DOSE COMPARISON; DRUG WITHDRAWAL; DYSLIPIDEMIA; FEMALE; HEALTH CARE UTILIZATION; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; OUTPATIENT; PRIORITY JOURNAL; PSORIASIS; SYSTEMIC THERAPY; TOPICAL TREATMENT; ADOLESCENT; MIDDLE AGED; PATHOPHYSIOLOGY; RETROSPECTIVE STUDY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; FEMALE; HUMANS; MALE; MIDDLE AGED; PSORIASIS; RETROSPECTIVE STUDIES; USTEKINUMAB; YOUNG ADULT;

EID: 84930810818     PISSN: 09546634     EISSN: 14711753     Source Type: Journal    
DOI: 10.3109/09546634.2014.883059     Document Type: Article

References (8)

1. About Psoriasis. National Psoriasis Foundation. Available from http://www.psoriasis.org/learn-statistics. Accessed on November 14, 2011.
2. Friedewald VE, Cather JC, Gelfand JM, et al. AJC's editor consensus: psoriasis and coronary artery disease. Am J Cardiol. 2008;102:1631-43.
3. Sterry W, Barker J, Boehncke WH, et al. Biologic therapies in the systemic management of psoriasis: international consensus conference. Brit J Dermatol. 2004;151:3-17.
4. Kurd SK, Troxel AB, Crits-Christoph P, Gelfand JM. The risk of depression, anxiety, and suicidality in patients with psoriasis: a population-based cohort study. Arch Dermatol. 2010; 146:89-95.
5. Schön MP, Boehncke WH. Psoriasis. N Engl J Med. 2005;352: 1899-912.
6. Stelara-(ustekinumab) prescribing information. Horsham, PA: Centocor Ortho Biotech Inc.
7. Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40:373-83.
8. Romano PS, Roos LL, Jollis JG. Adapting a clinical comorbidity index for use with ICD-9-CM administrative data: differing perspectives. J Clin Epidemiol. 1993;46:1075-9.